Modified EAET for prediabetes for Prediabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
PrediabetesModified EAET for prediabetes - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if a new therapy can help people with prediabetes.

Eligible Conditions
  • Prediabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: Change from baseline to 3-month follow-up and 6-month follow-up

Change from baseline to 3-month follow-up and 6-month follow-up
Body mass index
C-peptide
HbA1c
Health behavior
Perceived Stress Scale

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Modified EAET for Prediabetes
1 of 1

Experimental Treatment

16 Total Participants · 1 Treatment Group

Primary Treatment: Modified EAET for prediabetes · No Placebo Group · N/A

Modified EAET for Prediabetes
Behavioral
Experimental Group · 1 Intervention: Modified EAET for prediabetes · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Modified EAET for prediabetes
2022
N/A
~20

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline to 3-month follow-up and 6-month follow-up

Who is running the clinical trial?

Wayne State UniversityLead Sponsor
288 Previous Clinical Trials
104,625 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a HbA1C value of 5.7% to 6.4%.